This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genfit. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Maryline Bourotte: Innovator in Pharmaceutical Research
Introduction
Maryline Bourotte is a prominent inventor based in Perenchies, France. She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for various health-related issues.
Latest Patents
Maryline Bourotte's latest patents include the development of derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists. These novel compounds are designed to activate Rev-Erb, which has therapeutic effects in treating diseases related to inflammation, circadian rhythm disorders, and cardiometabolic conditions. The pharmaceutical compositions comprising these compounds offer promising avenues for effective treatment options.
Career Highlights
Throughout her career, Maryline has worked with notable companies such as Genfit and Galderma Research & Development. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research and development.
Collaborations
Maryline has collaborated with esteemed colleagues, including Jean-Francois Delhomel and Mathieu Dubernet. These partnerships have further enriched her research endeavors and have led to innovative breakthroughs in her field.
Conclusion
Maryline Bourotte stands out as a dedicated inventor whose work in pharmaceutical research has the potential to impact various health conditions positively. Her innovative patents and collaborations highlight her commitment to advancing medical science.